Efficacy of silymarin on calprotectin and S100A12/EN-RAGE in chemotherapy-induced oral mucositis
Dental and Medical Problems · 30.06.2026 · (3) · 597-606
DOI: 10.17219/dmp/186085 ↗Kurz gefasst
Fachartikel in der Zeitschrift Dental and Medical Problems, online erschienen am 30.06.2026. Verfasst von Aysar Amer Hameed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Isra University, Amman, Jordan. Hauptthemen laut MEDLINE: Stomatitis, Silymarin, Leukocyte L1 Antigen Complex, S100A12 Protein. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Oral mucositis (OM) is an oral complication of chemotherapy with agents such as 5-fluorouracil (5-FU). Silymarin (SM) has been utilized therapeutically as a cytoprotective medication. OBJECTIVES: The aim of the study was to evaluate the efficacy of SM as a mucoprotective agent in the treatment of chemotherapy-induced oral mucositis (CIOM) induced by 5-FU, and to assess calprotectin (CP) and S100A12/EN-RAGE levels as novel biomarkers for the evaluation of mucositis. MATERIAL AND METHODS: Fifty Wistar albino rats of both sexes were divided randomly into 5 groups. Three groups were treated with different doses of SM (2 mg/kg, 4 mg/kg, 6 mg/kg) for 10 days. Subsequently, the animals from groups I-III received intraperitoneal injections of 5-FU (60 mg/kg) on days 11-14. The 4th group was treated with dimethyl sulfoxide (DMSO) as a control for 10 days, followed by 2 doses of 5-FU, and the 5th group served as a second control and received 5-FU only. The buccal mucosa of the animals was gently injured with a 0.8-mm orthodontic wire (2×6 strokes) under anesthesia. The efficacy of SM treatment on CP and S100A12/EN-RAGE levels in CIOM was evaluated. Macroscopic and histopathological findings were analyzed, and the correlation coefficients between the studied parameters were calculated. RESULTS: The study demonstrated a significant protective effect of SM in chemotherapy-induced buccal mucositis in a dose-dependent manner. Mucositis ulceration was not observed, in contrast to severe OM lesions noted in the control groups. Analysis using a 95% confidence interval (CI) showed highly significant differences between the groups regarding the levels of CP and S100A12/EN-RAGE, as well as very strong correlations with OM ulcers. CONCLUSIONS: Based on the macroscopic and histopathological appearance, the study confirmed the dose-dependent protective efficacy of SM treatment in CIOM. In addition, the findings suggest a novel mucoprotective mechanism of SM mediated through its effects on CP and S100A12/EN-RAGE levels. A very strong positive correlation was found between plasma CP and S100A12/EN-RAGE levels and the presence of OM ulcers, suggesting that these biomarkers may be useful in the clinical assessment of CIOM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Isra University, Amman, Jordan.
- Department of Medical Education, Dr. Kiran C. Patel College of Allopathic Medicine, Nova Southeastern University, Davie, USA.
Zitieren
APA
Hameed, A. A., Altaei, T., & Alani, R. (2026). Efficacy of silymarin on calprotectin and S100A12/EN-RAGE in chemotherapy-induced oral mucositis. Dental and Medical Problems, 597-606. https://doi.org/10.17219/dmp/186085
Vancouver
Hameed AA, Altaei T, Alani R. Efficacy of silymarin on calprotectin and S100A12/EN-RAGE in chemotherapy-induced oral mucositis. Dental and Medical Problems. 2026:597-606. doi:10.17219/dmp/186085
BibTeX
@article{Hameed2026,
author = {Hameed, Aysar Amer and Altaei, Taghreed and Alani, Raad},
title = {Efficacy of silymarin on calprotectin and S100A12/EN-RAGE in chemotherapy-induced oral mucositis},
journal = {Dental and Medical Problems},
year = {2026},
number = {3},
pages = {597--606},
doi = {10.17219/dmp/186085}
}
EUVIMED